Shares of BioXcel Therapeutics Inc (NASDAQ:BTAI) have been given an average rating of “Buy” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among analysts that […]